The ability to rapidly and accurately identify the presence of diseases would provide clinicians with the ability to reduce suffering of their patients, the use of antibiotics, and healthcare costs that result from mis- or missed diagnoses.
Since Ionica Sciences was founded by Dr. Omar Green and Dr. Joel Tabb in 2013, we have been developing a platform disease diagnostic that has the flexibility to detect vector borne, sexually transmitted, and neurological diseases, among others. Combining well established spectroscopic methods, with new materials tailored for use this setting, and statistical methods, this approach has the potential to change how many diseases are diagnosed.
Our initial target is Lyme disease, the fastest growing vector borne disease in the United States, according to the CDC. The improved test, IonLyme, will provide clinicians critical information not available to them currently, allow Ionica to demonstrate the principle of the platform, and rapidly expand the diseases that can be identified using this cutting edge technology.
Ionica Sciences is headquartered at the McGovern Center, the biotechnology incubator on Cornell University’s campus in Ithaca, NY.
Learn more about IonLyme specifically, or the platform approach here.